Jae Young Hur
Overview
Explore the profile of Jae Young Hur including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
351
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Batochir C, Kim I, Jo E, Kim E, Kim H, Hur J, et al.
Cancers (Basel)
. 2024 Aug;
16(15).
PMID: 39123492
Benign lung diseases are common and often do not require specific treatment, but they pose challenges in the distinguishing of them from lung cancer during low-dose computed tomography (LDCT). This...
2.
Kim I, Hur J, Kim H, Kim W, Lee K
Transl Lung Cancer Res
. 2023 Aug;
12(7):1425-1435.
PMID: 37577304
Background: In our previous study, epidermal growth factor receptor () genotyping using extracellular vesicles (EV)-derived DNA isolated from bronchoalveolar lavage fluid (BALF) was proven to be highly concordant with conventional...
3.
Kim I, Hur J, Kim H, Kim W, Lee K
Cancers (Basel)
. 2022 Jun;
14(11).
PMID: 35681723
To overcome the limitations of the tissue biopsy and plasma cfDNA liquid biopsy, we performed the EV-based BALF liquid biopsy of 224 newly diagnosed stage III-IV NSCLC patients and compared...
4.
Hwang J, Hur J, Kim Y, Im J, Jin S, Ryu S, et al.
Transl Cancer Res
. 2022 Feb;
10(2):1025-1033.
PMID: 35116429
Background: Accumulating evidences indicate that AXL overexpression or activation is associated with cancer progression and acquired resistance to targeted anti-cancer drugs such as epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs)....
5.
Hur J, Lee K
Cancers (Basel)
. 2021 Aug;
13(15).
PMID: 34359729
Extracellular vesicles (EVs) carry RNA, proteins, lipids, and diverse biomolecules for intercellular communication. Recent studies have reported that EVs contain double-stranded DNA (dsDNA) and oncogenic mutant DNA. The advantage of...
6.
Kim I, Hur J, Kim H, Lee S, Hwang J, Kim W, et al.
Cancers (Basel)
. 2021 Jul;
13(14).
PMID: 34298845
Targeted NGS, widely applied to identify driver oncogenes in advanced lung adenocarcinoma, may also be applied to resected early stage cancers. We investigated resected -mutated lung adenocarcinoma mutation profiles to...
7.
Lee S, Park H, Hur J, Kim H, Kim I, Kim W, et al.
Transl Lung Cancer Res
. 2021 Feb;
10(1):104-116.
PMID: 33569297
Background: Extracellular vesicles (EVs) are membrane-bound and nanometer-sized particles released from most types of cells, containing double-stranded DNA reflecting mutational status of the parental tumor cells. Furthermore, epidermal growth factor...
8.
Kim I, Hur J, Kim H, Park J, Hwang J, Lee S, et al.
Ann Surg Oncol
. 2020 Nov;
28(7):3983-3993.
PMID: 33140254
Background: Despite surgical resection, early lung adenocarcinoma has a recurrence rate of 20-50%. No clear predictive markers for recurrence of early lung adenocarcinoma are available. Targeted next-generation sequencing (NGS) is...
9.
Kim I, Hur J, Kim H, Lee S, Kim W, Lee K
J Pathol Transl Med
. 2020 Oct;
54(6):453-461.
PMID: 33027851
Blood liquid biopsy has emerged as a way of overcoming the clinical limitations of repeat biopsy by testing for the presence of acquired resistance mutations to therapeutic agents. Despite its...
10.
Chang S, Hur J, Choi Y, Lee C, Kim W
J Pathol Transl Med
. 2020 May;
54(3):204-212.
PMID: 32460474
With advances in target therapy, molecular analysis of tumors is routinely required for treatment decisions in patients with advanced non-small cell lung cancer (NSCLC). Liquid biopsy refers to the sampling...